Clinical trials

Only want trials near your city that fit you? Get alerts

Disease

Country

Status

Phase

Reset

31,147 trials

NCT07237750
Recruiting
iWAIST Trial: ERCG (Endoscopic Radial Compression Gastroplasty) +Optimized Lifestyle Intervention (OLI) vs Sham + OLI for Weight Loss
Not applicable · China · 1 site
Registry update: 26 Oct 2026
NCT07338461
Recruiting
High Resolution Imaging OCT Study
Not applicable · Italy · 1 site
Registry update: 26 Aug 2026
NCT07073066
Recruiting
Deep Cervical Lymphatic Venous Anastomosis in the Treatment of Alzheimer's Disease (CLEAN-AD)
Not applicable · China · 9 sites
Registry update: 12 May 2026
NCT07545395
Recruiting
Safety of KN057 Prophylaxis in Patients With Haemophilia A or B
Phase 3 · China · 1 site
Registry update: 22 Apr 2026
NCT06833853
Recruiting
A Study for CTC Expression and cfDNA/RNA Assessment in Metastatic Breast Cancer Patients
Not applicable · United States · 1 site
Registry update: 18 Mar 2026
NCT07221149
Recruiting
A Study to Evaluate the Safety and Efficacy of Pumitamig in Combination With Chemotherapy Versus Nivolumab in Combination With Chemotherapy in Participants With Previously Untreated Advanced or Metastatic Gastric, Gastroesophageal Junction, or Esophageal Adenocarcinoma (ROSETTA Gastric-204)
Phase 2/3 · Argentina, Australia, Brazil, Canada, Chile, China, Colombia, Germany, Spain, France, United Kingdom, India, Italy, Japan, South Korea, Mexico, Poland, Romania, United States · 162 sites
Registry update: 5 Nov 2026
NCT07532863
Recruiting
A Real-world Study to Investigate Cardiovascular Risk Profile Among Newly Diagnosed Type 2 Diabetes Mellitus (T2DM) Participants
Not applicable · Indonesia, Malaysia, Philippines, Singapore · 6 sites
Registry update: 28 Jul 2026
NCT07456033
Recruiting
A Study of Efficacy and Safety of Depemokimab Compared With Placebo in Adults and Adolescents With at Risk Type 2 Asthma
Phase 3 · Belgium, Bulgaria, Czechia, Germany, Spain, France, United Kingdom, Ireland, Italy, Romania, United States · 94 sites
Registry update: 17 Aug 2026
NCT07371455
Recruiting
A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of LWP779 in Healthy Participants
Phase 1 · Australia · 1 site
Registry update: 20 Mar 2026
NCT07419828
Recruiting
A Phase III Clinical Study on the Efficacy and Safety of HRS-1780 in the Treatment of Patients With Chronic Kidney Disease
Phase 3 · China · 1 site
Registry update: 17 Jul 2026
NCT07299071
Recruiting
Efficacy of CAD in Screening Colonoscopy to Reduce the Risk of Advanced Adenoma at 3 Years.
Not applicable · France · 15 sites
Registry update: 24 Sept 2026
NCT07620834
Recruiting
Artificial Intelligence-Guided Diagnosis for High-Risk Osteoporosis Populations: A Pragmatic Randomized Clinical Trial
Not applicable · Taiwan · 3 sites
Registry update: 2 Jun 2026
NCT06705686
Recruiting
Novel ACK1 Inhibitor (R)-9b in Patients With Prostate Cancer
Phase 1 · United States · 1 site
Registry update: 20 Mar 2026
NCT07396805
Recruiting
Trial of Food Is Medicine Approaches for Obesity Treatment in Adults With Food Insecurity
Not applicable · United States · 1 site
Registry update: 16 Mar 2026
NCT07407647
Recruiting
Vaginal DHEA to Improve Vaginal Health After Radiation for Women With Gynecologic, Anal or Rectal Cancer
Phase 2 · United States · 1 site
Registry update: 21 Apr 2026
NCT07475806
Recruiting
A Study to Find Out if Enfortumab Vedotin Given With Pembrolizumab Helps People With Muscle-invasive Bladder Cancer Keep Their Bladder
Phase 2 · Australia, Canada, China, Germany, Spain, France, United Kingdom, Italy, Japan, South Korea, Poland, United States · 68 sites
Registry update: 2 Nov 2026
NCT07347678
Recruiting
Phase 1a Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of RN5681 in Healthy Volunteers
Phase 1 · Australia · 2 sites
Registry update: 3 Apr 2026
NCT07451769
Recruiting
Selective Activation of the Adrenomedullin Receptors in Migraine
Not applicable · Denmark · 1 site
Registry update: 28 Aug 2026
NCT07077213
Recruiting
18F-Fibroblast Activation Protein Inhibitor (18F-FAPI-74) in Tuberculosis Patients
Not applicable · United States · 1 site
Registry update: 31 Mar 2026
NCT07400731
Recruiting
Short and Long-term Responses of PD Symptoms to Earstim
Not applicable · 2 sites
Registry update: 23 Apr 2026

Ordered by registry start date. Freshness and sponsorship never change the order.